相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Loss of vagal anti-inflammatory effect: in vivo visualization and adoptive transfer
Caitlin O'Mahony et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2009)
Stimulation of Nicotinic Acetylcholine Receptors Attenuates Collagen-Induced Arthritis in Mice
Marjolein A. van Maanen et al.
ARTHRITIS AND RHEUMATISM (2009)
Vagus Nerve Activity Augments Intestinal Macrophage Phagocytosis via Nicotinic Acetylcholine Receptor alpha 4 beta 2
Esmerij P. van der Zanden et al.
GASTROENTEROLOGY (2009)
Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis
Masako Murai et al.
NATURE IMMUNOLOGY (2009)
The vagus nerve as a modulator of intestinal inflammation
E. P. Van der Zanden et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2009)
Guide to receptors and channels (GRAC), 3rd edition
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans
I. Wessler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
Jeffrey C. Barrett et al.
NATURE GENETICS (2008)
The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation
W. J. de Jonge et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Activation of the cholinergic anti-inflammatory pathway ameliorates postoperative ileus in mice
Frans O. The et al.
GASTROENTEROLOGY (2007)
The protective effect of the vagus nerve in a murine model of chronic relapsing colitis
Jean-Eric Ghia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Unravelling the pathogenesis of inflammatory bowel disease
R. J. Xavier et al.
NATURE (2007)
Expression and function of genes encoding cholinergic components in murine immune cells
Koichiro Kawashima et al.
LIFE SCIENCES (2007)
Nicotine Protects Kidney from Renal Ischemia/Reperfusion Injury through the Cholinergic Anti-Inflammatory Pathway
Claude Sadis et al.
PLOS ONE (2007)
Nicotine alters the biological activities of developing mouse bone marrow-derived dendritic cells (DCs)
M. Nouri-Shirazi et al.
IMMUNOLOGY LETTERS (2007)
Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease
Anie A. te Velde et al.
INFLAMMATORY BOWEL DISEASES (2007)
Guidelines on nicotine dose selection for in vivo research
Shannon G. Matta et al.
PSYCHOPHARMACOLOGY (2007)
Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis
Victoria E. McGilligan et al.
INFLAMMATORY BOWEL DISEASES (2007)
The vagus nerve: A tonic inhibitory influence associated with inflammatory bowel disease in a murine model
Jean Eric Ghia et al.
GASTROENTEROLOGY (2006)
Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria
N Kamada et al.
JOURNAL OF IMMUNOLOGY (2005)
Mechanisms of Disease: nicotine - a review of its actions in the context of gastrointestinal disease
GAO Thomas et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2005)
Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve
MD Luyer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
The vagus nerve and the nicotinic anti-inflammatory pathway
L Ulloa
NATURE REVIEWS DRUG DISCOVERY (2005)
The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis
H Tokuyama et al.
INTERNATIONAL IMMUNOLOGY (2005)
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
WJ de Jonge et al.
NATURE IMMUNOLOGY (2005)
Increased severity of experimental colitis in alphaS nicotinic acetylcholine receptor subunit-deficient mice
A Orr-Urtreger et al.
NEUROREPORT (2005)
The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis
DJ van Westerloo et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
H Wang et al.
NATURE MEDICINE (2004)
Inflammatory bowel disease and smoking -: A review of epidemiology, pathophysiology, and therapeutic implications
T Birrenbach et al.
INFLAMMATORY BOWEL DISEASES (2004)
Nicotine enemas for treatment of ulcerative colitis: a study of the pharmacokinetics and adverse events associated with three doses of nicotine
JR Ingram et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice
A Ogawa et al.
CLINICAL IMMUNOLOGY (2004)
The immunological and genetic basis of inflammatory bowel disease
G Bouma et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice
N Watanabe et al.
DIGESTIVE DISEASES AND SCIENCES (2003)
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
H Wang et al.
NATURE (2003)
Chronic nicotine administration differentially alters jejunal and colonic inflammation in interleukin-10 deficient mice
R Eliakim et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine
K Matsunaga et al.
JOURNAL OF IMMUNOLOGY (2001)
(-)-spiro[1-azabicyclo[2.2.2]octane-3,5′-oxazolidin-2′-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the α7 nicotinic acetylcholine receptor
G Mullen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease
AP Sykes et al.
INFLAMMATION RESEARCH (2000)
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
LV Borovikova et al.
NATURE (2000)